Hyperhidrosis Product

Focal Hyperhidrosis

TheraVida is a Chapel Hill, North Carolina based clinical stage specialty pharmaceutical company focused on the development of Anhydrix™ for the treatment of primary focal hyperhidrosis. Anhydrix™’s systemic approach gives it the unique potential to address patients suffering from both primary focal and secondary generalized hyperhidrosis.

We successfully completed a Phase 2 trial of Anhydrix™ and licensed the product to Dermavant Sciences for worldwide development.